The Retina Research Institute of Mississippi (RRIM) is a state-of-the-art facility dedicated to researching and evaluating new treatments for retina diseases. In partnership with Retina Consultants of America, Mississippi Retina Associates is committed to fighting against blindness by participating in cutting-edge clinical trials. With over 37 years of experience, our highly qualified physicians and staff are dedicated to promoting healthy vision.
Retina research is critical for improving patient outcomes, understanding complex diseases, developing new therapies, advancing medical knowledge, and improving patient safety. Our fully staffed research division is committed to finding treatment options for patients through ophthalmic research and clinical trials. Our highly qualified physicians are actively involved in nationwide medical studies covering various eye diseases and new surgical techniques.
We prioritize the use of cutting-edge diagnostic equipment to offer our patients the most advanced retina imaging and testing available. We are the only facility in Mississippi that provides access to a comprehensive range of new technology.
CLINICAL TRIALS & Vision ANALYSIS
Clinical trials are a vital part of our research efforts and offer the opportunity to access potential treatments before they are widely available to the public. Our commitment to maintaining healthy vision at every stage of life drives our participation in nationwide clinical trials for a range of retina conditions. Our ongoing trials focus on improving outcomes for patients with retinal diseases, and if you’re interested in participating, please ask your doctor.
Our research studies also include clinical trials to test new therapies not otherwise available in Mississippi. These include cutting-edge medications, innovative devices, or surgical techniques in patients with retinal conditions. By enrolling in a clinical trial, individuals with little option for treatment or who are not seeing positive results can access promising new therapies. Additionally, Retina Research of Mississippi offers patients access to unique imaging and vision screenings not commonly found in our area, further enhancing our commitment to comprehensive eye care.
DIAGNOSTIC IMAGING
- Fundus Photography
- Color Imaging
- Autofluorescence Imaging
- Fluorescein Angiography (FA)
- Retinal Angiography
- Iris Angiography
- Indocyanine Green Angiography (ICG)
- Spectral Domain Optical Coherence Tomography (SD-OCT)
FORMAL VISION SCREENING
- Visual Field
- Microperimetry
- Color Vision
- Contrast Sensitivity
- Visual Acuity
- Low Luminance Visual Acuity
- Low Vision Speed Reading
- Stereopsis
Clinical Trial FAQs
A clinical trial is a research study designed to evaluate the safety and effectiveness of new medical treatments, interventions, or drugs in human participants. These studies are conducted under strict guidelines and oversight by medical professionals and researchers to collect data on how the treatment impacts participants’ health.
Participating in a clinical trial offers patients access to new treatments not yet available to the public, potentially leading to improved health outcomes. Additionally, patients may find better ways to manage their symptoms through innovative approaches explored in the trial. By taking part, patients also contribute to advancing medical knowledge, helping researchers develop better treatments and care practices for future generations.
At the Retina Research Institute of Mississippi, we are committed to pioneering groundbreaking clinical trials in the near future.
We are excited to announce that we have exciting clinical trials in the pipeline that will offer promising new treatments and therapies for retinal diseases. These trials will represent the latest advancements in medical science and reflect our unwavering dedication to providing our patients with access to cutting-edge care.
Clinical trials are conducted in several phases, each with specific objectives aimed at evaluating the safety and effectiveness of a new drug or treatment.
Phase I: This initial phase involves a small group of participants and focuses primarily on assessing the safety of the drug or treatment. Researchers closely monitor participants for any adverse reactions and determine the appropriate dosage.
Phase II: In Phase II, the drug or treatment is administered to a larger group of participants to further evaluate its safety and efficacy. This phase provides additional data on the drug’s potential benefits and side effects.
Phase III: Phase III trials involve even larger groups of participants and focus on comparing the new drug or treatment to existing standard treatments. Researchers assess effectiveness while closely monitoring for any adverse reactions. This phase provides crucial information for regulatory approval and widespread use.
Phase IV: After a drug or treatment receives regulatory approval and is on the market, Phase IV trials may be conducted. These trials aim to gather additional information on the drug’s long-term effects, safety in a broader patient population, and potential interactions with other medications.
Overall, each phase of a clinical trial plays a vital role in advancing medical knowledge and improving patient care by ensuring the safety and effectiveness of new treatments.
Clinical trials serve as a cornerstone in advancing retina care by offering patients access to innovative treatments and contributing to the continuous improvement of existing therapies. While it’s impossible to guarantee the success of any treatment, clinical trials provide patients with either a promising new treatment or the best available conventional treatment, tailored specifically to address retinal diseases.
Clinical trials have been instrumental in introducing some of the most advanced treatments available today. These trials play a crucial role in evaluating the safety and efficacy of novel therapies, leading to the development of more effective strategies for managing retinal diseases. By participating in clinical trials, patients not only gain access to cutting-edge treatments but also contribute to the collective knowledge of retinal diseases, ultimately paving the way for better care and outcomes for future patients.
While the outcomes of clinical trials cannot be guaranteed, their effectiveness in advancing retina care is undeniable. Through ongoing research and participation in clinical trials, we continue to push the boundaries of what is possible in the treatment of retinal diseases, offering hope and improved quality of life for patients worldwide.
Are you a candidate?
To learn more about our upcoming clinical trials the Retina Research Institute of Mississippi and determine if you qualify as a participant, please contact our office. Our team of specialists is available to provide you with detailed information and guidance on enrollment. Take the first step towards potentially benefiting from groundbreaking treatments and contributing to the advancement of retina care by reaching out to us today.